Rotavirus Vaccine

Folkehelseinstituttet

Folkehelseinstituttet [the Norwegian Institute of Public Health] is implementing an open tender competition for the procurement of vaccine against rota virus for the base vaccination of infants in the Norwegian child vaccination programme, starting up in Q2 2019.
The competition is carried out as an open competitive tender, a one step process where all interested suppliers may submit a tender. Negotiations are not allowed. The objective of the procurement is to enter into a contract for the delivery of the rotavirus vaccine for base vaccination of infants in the Norwegian Child Vaccination Programme. The start of vaccination under the new agreement is anticipated to occur in Q2/Q3 2019.
In addition to the information in KGV< the attached tender documentation provides information and rules for the competition.

Frist

Fristen for mottak av tilbud var 2018-08-01. Anskaffelsen ble publisert 2018-06-01.

Hvem? Hva? Hvor?
Anskaffelseshistorikk
Dato Dokument
2018-06-01 Kunngjøring av konkurranse
2018-06-07 Kunngjøring om tildeling av kontrakt
Kunngjøring av konkurranse (2018-06-01)
Gjenstand
Anskaffelsens omfang
Tittel: Vaccines
Referansenummer: 18/10867
Kort beskrivelse:
Folkehelseinstituttet [the Norwegian Institute of Public Health] is implementing an open tender competition for the procurement of vaccine against rota virus for the base vaccination of infants in the Norwegian child vaccination programme, starting up in Q2 2019. The competition is carried out as an open competitive tender, a one step process where all interested suppliers may submit a tender. Negotiations are not allowed. The objective of the procurement is to enter into a contract for the delivery of the rotavirus vaccine for base vaccination of infants in the Norwegian Child Vaccination Programme. The start of vaccination under the new agreement is anticipated to occur in Q2/Q3 2019. In addition to the information in KGV< the attached tender documentation provides information and rules for the competition.
Vis mer
Metadata for kunngjøring
Originalspråk: engelsk 🗣️
Dokumenttype: Kunngjøring av konkurranse
Kontraktens art: Varer
Forskrift: Det europeiske økonomiske samarbeidsområdet (EØS), med deltakelse av GPA-land
Felles innkjøpsordliste (CPV)
Kode: Vaksiner 📦
Tilleggs-CPV: Vaksiner 📦
Utførelsessted
NUTS-region: Norge 🏙️

Prosedyre
Prosedyretype: Åpen anbudskonkurranse
Tilbudstype: Innlevering for alle delkontrakter
Tildelingskriterier
Det mest økonomisk fordelaktige tilbudet

Oppdragsgiver
Identitet
Land: Norge 🇳🇴
Type tildelende myndighet: Departement eller annen nasjonal eller føderal myndighet
Navn på tildelende myndighet: Folkehelseinstituttet
Postadresse: Lovisenberggata 8
Postnummer: 0456
Poststed: Oslo
Kontakt
Internettadresse: http://www.fhi.no 🌏
E-post: ole.andreas.fuglesang@fhi.no 📧
Telefon: +47 21077000 📞
URL for dokumenter: http://eu.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=211167&B=DFO 🌏
URL for deltakelse: http://eu.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=211167&B=DFO 🌏

Referanse
Datoer
Sendt dato: 2018-06-01 📅
Innleveringsfrist: 2018-08-01 📅
Publiseringsdato: 2018-06-02 📅
Identifikatorer
Kunngjøringsnummer: 2018/S 104-238612
OJ-S-utgave: 104
Tilleggsinformasjon
With reference to point II.2.7 about Duration etc. the Norwegian Institute of Public Health emphasises that the agreement duration of 48 months, is a maximum length, but the agreement can be terminated earlier in accordance with provisions in the Supply Agreement (the Contract) point 14. With reference to point II.2.6, the Norwegian Institute of Public Health emphasis that the stated value is the maximum value in a loosely estimated value range from 48 000 000 NOK to 74 000 000 NOK.
Vis mer

Gjenstand
Anskaffelsens omfang
Kort beskrivelse:
Folkehelseinstituttet [the Norwegian Institute of Public Health] is implementing an open tender competition for the procurement of vaccine against rota virus for the base vaccination of infants in the Norwegian child vaccination programme, starting up in Q2 2019.
Vis mer
The competition is carried out as an open competitive tender, a one step process where all interested suppliers may submit a tender. Negotiations are not allowed. The objective of the procurement is to enter into a contract for the delivery of the rotavirus vaccine for base vaccination of infants in the Norwegian Child Vaccination Programme. The start of vaccination under the new agreement is anticipated to occur in Q2/Q3 2019.
Vis mer
In addition to the information in KGV< the attached tender documentation provides information and rules for the competition.
Estimert totalverdi: 74 000 000 NOK 💰
Estimert verdi eksklusive mva: 74 000 000 NOK 💰
Varighet: 48 måneder
Tilleggsinformasjon:
With reference to point II.2.7 about Duration etc. the Norwegian Institute of Public Health emphasises that the agreement duration of 48 months, is a maximum length, but the agreement can be terminated earlier in accordance with provisions in the Supply Agreement (the Contract) point 14.
Vis mer
With reference to point II.2.6, the Norwegian Institute of Public Health emphasis that the stated value is the maximum value in a loosely estimated value range from 48 000 000 NOK to 74 000 000 NOK.
Utførelsessted
Hovedsted eller utførelsessted: Oslo.

Juridisk, økonomisk, finansiell og teknisk informasjon
Vilkår for deltakelse
Egnethet til å utøve yrkesvirksomheten:
The tenderer shall be registered in a company register, professional register or a trade register in the state where the tenderer is established.
Documentation requirement:
Norwegian tenderers: Company Registration Certificate.
Foreign tenderers: Verification showing that the tenderer is registered in a company register, professional register or a commerce register in the country where the tenderer is established.
Økonomisk og finansiell stilling:
Requirement: The tenderer shall have sufficient economic and financial capacity to be able to fulfil the contract. Creditworthiness with no requirement for guarantees will be sufficient to meet the requirement.
Documentation requirement:
Credit rating based on the most recent financial figures. The rating shall be carried out by a credit rating company with licence to conduct this service,
Teknisk og faglig kapasitet:
Requirement: The tenderer shall have experience from comparable assignments.
Documentation requirement:
Description of the tenderer´s up to 3 most relevant contracts in the course of the last 3 years. The description must include an indication of the assignment product/scope or value, dates and recipients.. It is the tenderer´s responsibility to document relevance through the description.
Vis mer
Requirement: The tenderer shall have sufficient delivery capacity throughout the contract period.
Confirmation that the tenderer has the capacity to deliver a sufficient number of doses of the rotavirus vaccine to fulfil the contract.
Requirement: The tenderer shall have the requisite permissions to be able to fulfil the contract.
If the tenderer is the manufacturer of the vaccine, permission must be presented from relevant EU/EEA authorities to manufacture pharmaceuticals.
If the tenderer is not the manufacturer of the vaccine, the requisite permissions from relevant EU/EEA authorities to trade in pharmaceuticals must be presented. (NOTE: The documentation requirement continues on the next page).
If the tenderer imports the vaccine, the import license that includes the offered vaccine must be presented.
If the tenderer is not the manufacturer of the vaccine, the requisite permissions from relevant EU/EEA authorities to trade in pharmaceuticals must be presented.
Kontraktutførelse
Vilkår for kontraktoppfyllelse:
— The Norwegian Institute of Public Health requires ethical and socially responsible production. (Supply Agreement, point 10, 10.1 – 10.4),
— The tenderer shall be a member of the Legemiddelansvarsforeningen [Pharmaceutical Liability Association] (Supply Agreement, point 9.2),
— Folkehelseinstituttet [the Norwegian Institute of Public Health] can re-sell, non-distributed, vaccine doses (Supply Agreement, point 15.1),
— First delivery: A sufficient number of doses necessary to complete immunisation of 15 000 infants by 31.3.2019 (Supply Agreement, point 3.6),
— The tenderer is obligated to deliver the necessary number of doses to complete immunisation of 65 000 infants per calendar year. (Supply agreement point 3.3),
— Folkehelseinstituttet [the Norwegian Institute of Public Health] is obliged to purchase a minimum volume of the sufficient number of doses necessary to complete immunisation of 50 000 infants per calendar year during the agreement period. (Supply agreement point 3.2).
Vis mer

Prosedyre
Tidspunkt for mottak av tilbud: 13:00
Språk som tilbud eller forespørsler om deltakelse kan sendes inn på: engelsk 🗣️
norsk 🗣️
Tilbudets gyldighetsperiode: 2018-11-01 📅
Dato for åpning av tilbud: 2018-08-01 📅
Tidspunkt for åpning av tilbud: 13:00
Sted: Folkehelseinstituttet [the Norwegian Institute of Public Health], Oslo.
Tilleggsinformasjon:
2 employees of Folkehelseinstituttets Vaksineforsyning [the Norwegian Institute of Public Health’s Unit for Vaccine Supply], possibly the legal department.
Tildelingskriterier
Kvalitetskriterium (navn): Quality including Safety and Effect
Kvalitetskriterium (vekting): 50
Vekting av pris: 50

Oppdragsgiver
Identitet
Nasjonalt registreringsnummer: 983 744 516
Kontakt
Kontaktpunkt: Ole Andreas Fuglesang
Adresse til kjøperprofilen: https://eu.eu-supply.com/ctm/Company/CompanyInformation/Index/346372 🌏
URL for dokumenter: http://eu.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=211167&B=DFO 🌏

Utfyllende informasjon
Klageinstans
Navn: Klagenemndssekretariatet (KOFA)
Postadresse: Postboks 511 Sentrum
Poststed: Bergen
Postnummer: 5805
Land: Norge 🇳🇴
Kilde: OJS 2018/S 104-238612 (2018-06-01)
Kunngjøring om tildeling av kontrakt (2018-06-07)
Gjenstand
Anskaffelsens omfang
Kort beskrivelse:
The Norwegian institute of public health is cancelling the open tender competition for the procurement of vaccines against the rotavirus for the base vaccination of infants in the Norwegian child vaccination programme, starting up in Q2 2019. The competition is carried out as an open competitive tender, a one step process where all interested suppliers may submit a tender. Negotiations are not allowed. The objective of the procurement is to enter into a contract for the delivery of the rotavirus vaccine for base vaccination of infants in the Norwegian Child vaccination programme. The start of vaccination under the new agreement is anticipated to occur in Q2/Q3 2019. In addition to the information in KGV< the attached tender documentation provides information and rules for the competition.
Vis mer
Metadata for kunngjøring
Dokumenttype: Kunngjøring om tildeling av kontrakt

Prosedyre
Tilbudstype: Ikke aktuelt

Referanse
Datoer
Sendt dato: 2018-06-07 📅
Publiseringsdato: 2018-06-08 📅
Identifikatorer
Kunngjøringsnummer: 2018/S 108-247286
Refererer til kunngjøring: 2018/S 104-238612
OJ-S-utgave: 108
Tilleggsinformasjon
With reference to point II.2.7 about Duration etc. the Norwegian Institute of Public Health emphasises that the agreement duration of 48 months, is a maximum length, but the agreement can be terminated earlier in accordance with provisions in the supply agreement (the Contract) point 14. With reference to point II.2.6, the Norwegian Institute of public health emphasis that the stated value is the maximum value in a loosely estimated value range from 48 000 000 NOK to 74 000 000 NOK.
Vis mer

Gjenstand
Anskaffelsens omfang
Kort beskrivelse:
The Norwegian institute of public health is cancelling the open tender competition for the procurement of vaccines against the rotavirus for the base vaccination of infants in the Norwegian child vaccination programme, starting up in Q2 2019.
The competition is carried out as an open competitive tender, a one step process where all interested suppliers may submit a tender. Negotiations are not allowed. The objective of the procurement is to enter into a contract for the delivery of the rotavirus vaccine for base vaccination of infants in the Norwegian Child vaccination programme. The start of vaccination under the new agreement is anticipated to occur in Q2/Q3 2019.
Vis mer
The Norwegian Institute of Public Health is cancelling the open tender competition for the procurement of vaccines against the rotavirus for the base vaccination of infants in the Norwegian child vaccination programme, starting up in Q2 2019.
Tilleggsinformasjon:
With reference to point II.2.7 about Duration etc. the Norwegian Institute of Public Health emphasises that the agreement duration of 48 months, is a maximum length, but the agreement can be terminated earlier in accordance with provisions in the supply agreement (the Contract) point 14.
Vis mer
With reference to point II.2.6, the Norwegian Institute of public health emphasis that the stated value is the maximum value in a loosely estimated value range from 48 000 000 NOK to 74 000 000 NOK.

Prosedyre
Tildelingskriterier
Kvalitetskriterium (navn): Quality including safety and effect

Referanse
Tilleggsinformasjon
The competition must be cancelled due to an error in the tender documentation.
The Contracting Authority has reviewed one of the competition´s minimum requirements on the vaccine´s resistance against raised temperatures.
The minimum requirement is set to prevent unnecessary wastage due to minor temperature deviations. There are always requirements for procurements for the child vaccination programme that the vaccines in question must have a certain resistance against raised temperatures. Just how long a vaccine must be able to tolerate raised temperatures is assessed from procurement to procurement. In this procurement, the minimum requirement should have been set to 48 hours at minimum 25
Vis mer
The public procurement regulations (FOA) §14-2 (1) allow a Contracting Authority to make insignificant corrections, supplements and changes to the tender documentation.
The Contracting Authority is of the opinion that a change to one of the minimum requirements is to be seen as a significant change, as the change can affect participation in the competition. Any softening of the relevant minimum requirements within the announced competition would, therefore, be illegal.
Vis mer
Furthermore, the Contracting Authority is of the opinion that the only way to correct the error is to cancel the competition and then announce a new competition with the revised competition basis.
Pursuant to PPR § 25-4 (1) a Contracting Authority can cancel the competition with immediate effect if there is justifiable cause.
As the Contracting Authority has made an error that could limit the competition unnecessarily and which cannot be corrected in any other way, the Contracting Authority deems the justifiable cause requirement to be fulfilled.
The competition is cancelled and the Contracting Authority will announce a new competition.
Kilde: OJS 2018/S 108-247286 (2018-06-07)
Nye anskaffelser i relaterte kategorier 🆕
Relaterte søk 🔍
Produkter/tjenester:
Medisinsk utstyr, legemidler og utstyr... Farmasøytiske produkter Antiinfektive midler for systemisk bruk,... Antiinfektive midler for systemisk bruk Vaksiner